{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T17:22:58Z","timestamp":1761844978597},"reference-count":10,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","lipidjournal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.jacl.2019.02.006","type":"journal-article","created":{"date-parts":[[2019,3,6]],"date-time":"2019-03-06T16:43:57Z","timestamp":1551890637000},"page":"411-414","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Atypical familial dysbetalipoproteinemia associated with high polygenic cholesterol and triglyceride scores treated with ezetimibe and evolocumab"],"prefix":"10.1016","volume":"13","author":[{"given":"Anthony P.","family":"Morise","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert A.","family":"Hegele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacl.2019.02.006_bib1","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1194\/jlr.D045963","article-title":"LipidSeq: a next generation clinical resequencing panel for monogenic dyslipidemias","volume":"55","author":"Johansen","year":"2014","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacl.2019.02.006_bib2","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1161\/ATVBAHA.116.308027","article-title":"Polygenic versus monogenic causes of hypercholesterolemia ascertained clinically","volume":"36","author":"Wang","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"5","key":"10.1016\/j.jacl.2019.02.006_bib3","doi-asserted-by":"crossref","first-page":"360","DOI":"10.7326\/L17-0182","article-title":"Polygenic risk for hypertriglyceridemia can mimic a major monogenic mutation","volume":"167","author":"Stahel","year":"2017","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1016\/j.jacl.2019.02.006_bib4","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/j.jacl.2018.09.006","article-title":"The spectrum of type III hyperlipoproteinemia","volume":"12","author":"Sniderman","year":"2018","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2019.02.006_bib5","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jacl.2016.10.001","article-title":"Autosomal dominant familial dysbetalipoproteinemia: a pathophysiological framework and practical approach to diagnosis and therapy","volume":"11","author":"Koopal","year":"2017","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2019.02.006_bib6","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1007\/s11883-014-0440-2","article-title":"Hyperlipoproteinemia Type 3: the forgotten phenotype","volume":"16","author":"Hopkins","year":"2014","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.jacl.2019.02.006_bib7","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/s11883-014-0424-2","article-title":"Sitosterolemia: diagnosis, investigation, and management","volume":"16","author":"Escola-Gil","year":"2014","journal-title":"Curr Atheroscler Rep"},{"issue":"2","key":"10.1016\/j.jacl.2019.02.006_bib8","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/humu.9047","article-title":"Mutations in the Human ATP-Binding Cassette Transporters ABCG5 and ABCG8 in sitosterolemia","volume":"20","author":"Heimerl","year":"2002","journal-title":"Hum Mutat"},{"key":"10.1016\/j.jacl.2019.02.006_bib9","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.jacl.2017.10.013","article-title":"The association between hypercholesterolemia and sitosterolemia, and report of a sitosterolemia kindred","volume":"12","author":"Brinton","year":"2018","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2019.02.006_bib10","doi-asserted-by":"crossref","first-page":"9194736","DOI":"10.1155\/2018\/9194736","article-title":"The effect of proprotein convertase subtilisin\/kexin type 9 inhibitors on nonfasting remnant cholesterol in a real world population","volume":"2018","author":"Morise","year":"2018","journal-title":"J Lipids"}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287419300418?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287419300418?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,11]],"date-time":"2019-07-11T23:14:53Z","timestamp":1562886893000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933287419300418"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":10,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S1933287419300418"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2019.02.006","relation":{},"ISSN":["1933-2874"],"issn-type":[{"value":"1933-2874","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Atypical familial dysbetalipoproteinemia associated with high polygenic cholesterol and triglyceride scores treated with ezetimibe and evolocumab","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Lipidology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacl.2019.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 National Lipid Association. All rights reserved.","name":"copyright","label":"Copyright"}]}}